Picard Medical, Inc.

PMI NYSE SEC CIK 2030617
Follow Picard Medical Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $217K −81.7% vs same quarter last year
Net income −$2.2M +78.7% vs same quarter last year
EPS, diluted −$0.95 +90.1% vs same quarter last year
Operating cash flow −$2M +69.4% vs same quarter last year
Revenue by quarter
$836K
$620K
$2.1M
$1.2M
$1M
$1.2M
$3M
$217K
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing